Nath Bio Genes India Limited Stock Price Today (NSE: NATHBIOGEN)

Nath Bio Genes India Limited

174.972.47 (1.39%)
Market Open

Fundamental Score

...

Nath Bio Genes India Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Nath Bio Genes India Limited share price today is 174.97, down 1.39% on NSE/BSE as of 22 June 2026. Nath Bio Genes India Limited (NATHBIOGEN) is a Small-cap company in the Other Agricultural Products sector with a market capitalisation of 299.59 (Cr). The 52-week high for NATHBIOGEN share price is 238.69 and the 52-week low is 126.15. At a P/E ratio of 7.25x, NATHBIOGEN is currently trading below its industry average P/E of 21.07x. The company has a Return on Equity (ROE) of 6.23% and a debt-to-equity ratio of 0.23.

Nath Bio Genes India Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
204.00
Low
153.63
Volume
65.4K
Change
-0.91%

Nath Bio Genes India Limited share price chart: -0.91% return over the past month. 52-week high ₹238.69, 52-week low ₹126.15.

Nath Bio Genes India Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
176.54180.39173.00174.9721.08K (Cr)
176.08180.69172.10177.4464.81K (Cr)
172.20178.79172.00175.1832.94K (Cr)
171.26174.89169.36172.2040.11K (Cr)
173.05177.00170.35171.1120.52K (Cr)
172.82178.79172.82175.9229.60K (Cr)
174.00174.00169.94172.8317.32K (Cr)
168.54176.02166.92170.531.30L (Cr)
160.00168.78159.83166.8819.26K (Cr)
159.62162.99159.02160.278.80K (Cr)

Nath Bio Genes India Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
176.08180.69172.10174.97-0.63%
196.01197.62153.63175.18-10.63%
135.00204.00133.20196.01+45.19%
142.01150.01126.15129.02-9.15%
147.99157.89145.25150.07+1.41%
155.48164.99136.00147.86-4.90%
159.75163.13139.98155.49-2.67%
175.00176.90148.01156.40-10.63%
164.91181.90161.55173.68+5.32%
170.83179.70162.65164.91-3.47%
184.00185.00167.30170.83-7.16%
206.80238.69177.00182.21-11.89%

AI Research Briefing

Powered by Gemini · 2026-04-10

Micro-cap seed company with unsustainable earnings; avoid.

Research Confidence
7.0/10High
MICRO-CAP DARK HORSEBreakdown. 1M: -9.17%, 3M: -7.18%, 6M: -15.43% [cite: Brief]Cheap based on P/E, but quality is poor.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Nath Bio-Genes' stock rating was upgraded from Strong Sell to Sell on April 8, 2026, due to technical improvements, despite weak fundamentals. The stock is its 52-week low.

CORE STORY (THE REAL GAME)

Nath Bio-Genes is a play on the Indian hybrid and GM seed market, leveraged to rural agri demand and the vagaries of the monsoon. Not a tech disruptor, but a traditional agri-input company.

Why Now
  • Q3 2026 earnings beat
  • Low P/E relative to market
  • Short-term outperformance vs Sensex
Potential Catalysts
  • Good monsoon
  • Government seed subsidies
  • New product launches
Key Risks
  • Micro-cap liquidity risk
  • Weak ROCE
  • Erratic monsoons
Institutional Activity

FII down 0.09%, DII down 1.49% [cite: Brief]

Macro Context

Agri exports are a bright spot for India, but weather remains a key risk.

Cash Flow Quality

No Free Cash Flow 5Y [cite: Brief]

3–6 Month Outlook

Expect continued volatility based on weather patterns and commodity prices. Any sustained rally should be used to exit.

Primary Thesis Risk

Reliance on favorable weather and susceptibility to illegal BT cotton.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Poor

Return on Equity (ROE)

6.23%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

6.96%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Good

Dividend Yield

1.27%

Annual dividend as % of current share price

Nath Bio Genes India Limited Valuation Check

Excellent

Price to Earnings (P/E)

7.25x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

21.07x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

45.59%

% shares held by company founders/management

Poor

FII Holding

0.32%

% shares held by foreign institutional investors

Poor

DII Holding

0.76%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

13.78%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

126.13%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

36.22%

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.23x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

4.68x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

N/A

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Nath Bio Genes India Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of NATHBIOGEN across key market metrics for learning purposes.

Positive Indicators

4 factors identified

Attractive Valuation (P/E: 7.25 vs Industry: 21.07)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Robust Profit Growth (126.13%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (36.22%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Conservative Debt Levels (D/E: 0.23)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Risk Factors

3 factors identified

Below-Average Return on Equity (6.23%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (6.96%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Limited Institutional Interest (FII+DII: 1.08%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

Nath Bio Genes India Limited vs Other Agricultural Products Peers

Peer Comparison - Other Agricultural Products

Compare Nath Bio Genes India Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
27.2/100
175
₹299.59
7.3
Average
6.23%
Poor
6.96%
Poor
0.2
Excellent
1.27%
LT Foods Ltd...
LTFOODS532783
67.8/100
382
₹14419.68
22.7
Average
16.70%
Good
19.18%
Good
0.4
Excellent
26.37%
Excellent
15.99%
Excellent
0.72%
KRBL Ltd...
KRBL530813
54.6/100
346
₹9182.57
15.1
Average
9.42%
Poor
11.84%
Average
0.0
Excellent
-3.15%
Poor
4.45%
Average
0.87%
44.1/100
153
₹5195.38
25.2
Average
8.59%
Poor
11.46%
Average
0.1
Excellent
10.42%
Good
3.86%
Average
0.22%
56.1/100
872
₹5132.36
16.9
Average
19.04%
Good
20.08%
Excellent
0.0
Excellent
3.36%
Average
5.30%
Good
0.50%
48.3/100
154
₹2915.20
43.0
Average
16.03%
Good
13.50%
Average
0.4
Excellent
13.84%
Good
12.44%
Good
0.00%
Sanstar Ltd...
SANSTAR544217
45.7/100
113
₹1641.27
81.7
Average
9.63%
Poor
11.76%
Average
0.0
Excellent
129.68%
Excellent
29.55%
Excellent
0.00%
42.3/100
289
₹1277.19
13.6
Average
14.19%
Average
16.71%
Good
0.1
Excellent
14.42%
Good
13.39%
Good
0.97%
52.7/100
95
₹1096.07
39.5
Average
28.81%
Excellent
21.16%
Excellent
0.3
Excellent
58.19%
Excellent
28.28%
Excellent
0.00%
57.2/100
70
₹1038.52
16.9
Average
9.89%
Poor
12.84%
Average
0.2
Excellent
7.46%
Good
7.00%
Good
1.03%
45.7/100
183
₹838.46
19.6
Average
3.92%
Poor
6.31%
Poor
0.7
Good
2.79%
Average
26.61%
Excellent
0.22%

Nath Bio Genes India Limited PE Ratio History

Historical price-to-earnings ratio for NATHBIOGEN — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202520.14₹155.497.7x
FY 202421.34₹186.568.7x
FY 202318.43₹207.4011.3x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Nath Bio Genes India Limited Dividend History

Annual cash dividends paid by NATHBIOGEN — dividend yield 1.27%

Financial YearDividends Paid (₹ Cr)
FY 20253.80 Cr
FY 20243.80 Cr
FY 20233.80 Cr
FY 20223.80 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Nath Bio Genes India Limited Quarterly Performance

Latest quarterly metrics for NATHBIOGEN — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

36.22%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

126.13%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Nath Bio Genes India Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for NATHBIOGEN — calculated from daily price history

47RSI 14
Neutral — RSI 47

Momentum is balanced — neither overbought nor oversold.

SMA 50
160
▲ Price above SMA 50 — Short-term bullish
SMA 200
160
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
55K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Nath Bio Genes India Limited Financial Statements

Annual income statement, balance sheet and cash flow for Nath Bio Genes India Limited (NATHBIOGEN) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Nath Bio Genes India Limited

About NATHBIOGEN (Nath Bio Genes India Limited)

Nath Bio-Genes India Limited is a pioneering force in the realm of Indian agricultural innovation, focusing on developing and distributing cutting-edge solutions for enhancing crop... yields and promoting sustainable farming practices. The company is dedicated to researching, producing, and marketing a diverse portfolio of high-quality agricultural products beyond conventional seeds. These include bio-stimulants, soil conditioners, and crop protection agents, all designed to work synergistically with traditional farming methods to improve plant health and resilience. NATHBIOGEN aims to empower farmers with the tools and knowledge they need to maximize productivity while minimizing their environmental footprint, fostering a future where agriculture is both efficient and environmentally responsible. Beyond seeds, NATHBIOGEN is invested in the development of advanced agricultural technologies aimed at optimizing resource utilization and reducing crop losses. This includes precision farming solutions like drone-based crop monitoring and data-driven irrigation management systems. By leveraging the power of technology, NATHBIOGEN seeks to provide farmers with real-time insights into crop health, enabling them to make informed decisions about planting, fertilization, and pest control. This proactive approach to agriculture not only boosts crop yields but also minimizes the use of water, fertilizers, and pesticides, contributing to a more sustainable and environmentally friendly farming ecosystem. The company understands agriculture's ever-evolving landscape, and is actively exploring sustainable and regenerative agriculture practices to protect farmland. At the heart of NATHBIOGEN's operations is a deep commitment to farmer education and support. The company recognizes that simply providing innovative products is not enough; farmers need to understand how to effectively use these tools to achieve optimal results. To this end, NATHBIOGEN invests heavily in training programs, field demonstrations, and advisory services, ensuring that farmers have access to the knowledge and expertise they need to succeed. By building strong relationships with farmers and providing ongoing support, NATHBIOGEN aims to create a collaborative ecosystem where innovation and practical knowledge converge to drive sustainable agricultural growth and improve the livelihoods of farming communities across India and beyond.

Company Details

Symbol:NATHBIOGEN
Industry:Other Agricultural Products
Sector:Other Agricultural Products

Key Leadership

Mr. Satish Kagliwal
Executive Chairman & MD
Mr. Amol Arunrao Gupta
Chief Financial Officer
Mr. Dhiraj Rajesh Rathi
Company Secretary & Compliance Officer

Corporate Events

Recent
Ex-Dividend Date

NATHBIOGEN Share Price: Frequently Asked Questions

What is the current share price of Nath Bio Genes India Limited?

Nath Bio Genes India Limited (NATHBIOGEN) trades at ₹174.97 on NSE and BSE. Market cap ₹299.59 (Cr). Educational data only.

What is the P/E ratio of Nath Bio Genes India Limited?

Nath Bio Genes India Limited has a P/E of 7.25x vs industry average 21.07x.

What is the Bull Run score for Nath Bio Genes India Limited?

Nath Bio Genes India Limited has a Bull Run score of 27.2/100 based on 25+ financial parameters.

Does Nath Bio Genes India Limited pay dividends?

Nath Bio Genes India Limited has a dividend yield of 1.27%. Past dividends don't guarantee future payments.

What is the ROE of Nath Bio Genes India Limited?

Nath Bio Genes India Limited has ROE of 6.23%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Nath Bio Genes India Limited?

Nath Bio Genes India Limited has debt-to-equity of 0.23.

Is Nath Bio Genes India Limited a good investment?

Bull Run gives Nath Bio Genes India Limited a score of 27.2/100. This is not investment advice — consult a SEBI-registered advisor.